Is MAP2K1 p.Lys4Arg (c.11A>G) pathogenic?

MAP2K1 p.Lys4Arg (c.11A>G) is classified Uncertain significance in MAP2K1 (ClinVar, Multiple submitters, 3 submitters; last evaluated 2025-07-06). AlphaMissense: likely benign (0.0637); Very rare (popmax 0.00571%, amr); Associated with RASopathy.

What condition is associated with MAP2K1 p.Lys4Arg (c.11A>G)?

MAP2K1 p.Lys4Arg (c.11A>G) is associated with RASopathy (ClinVar).

How common is MAP2K1 p.Lys4Arg (c.11A>G) in the general population?

MAP2K1 p.Lys4Arg (c.11A>G) is very rare (popmax 0.00571%, amr) (gnomAD).

What do computational predictors say about MAP2K1 p.Lys4Arg (c.11A>G)?

AlphaMissense predicts likely benign (score 0.0637) — an in-silico prediction, not a clinical call.

MAP2K1 p.Lys4Arg

c.11A>G · rs761150136 · VCV496174

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 3 submitters

AlphaMissense

likely benign

0.0637 · ACMG-weighted

gnomAD v4.1

Rare

very rare (popmax 0.00571%, amr)

Missense predictors

0/2 damaging

AlphaMissense, SaProt · REVEL no call

Conditions

RASopathy

Computational evidence

Protein change
AlphaMissense	0.0637	likely benign
REVEL	0.371	indeterminate
SaProt	LLR -6.95	tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 10	GERP 1.3, phastCons 1
Regional constraint	o/e 1.04	unconstrained · MANE · 66 bp · p 0.84 · regional, not allelic
Overall
CADD	21.6	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.00571% Admixed American · 3/52,572 alleles

Filtering AF 0.00151% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00082%

Overall 0.000283% 4/1,411,230 alleles · very rare

Ancestry group	Frequency	1 in
Admixed Americangrpmax	0.00571%	17,524
European (non-Finnish)	8.67e-05%	1,153,288

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: MAP2K1
Protein: p.Lys4Arg
Coding: c.11A>G
MANE Select: NM_002755
dbSNP: rs761150136
Type: single nucleotide variant
Location: chr15:66387358 (GRCh38)
Gene constraint: LOEUF 0.515 · pLI 0.97 · ClinGen HI 0/3 (gnomAD)
Structure: AlphaFold pLDDT 84.05 · 99 PDB
Residue 4: the 'disordered' region

Full MAP2K1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

RASopathy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

MAP2K1 p.Lys4= Likely benign ★★ same residue
MAP2K1 p.Arg108Leu Likely pathogenic ★★★ same condition
MAP2K1 p.Asn122Asp Pathogenic ★★★ ⚠ same condition
MAP2K1 p.Asp67Asn Pathogenic ★★★ same condition
MAP2K1 p.Glu203Gly Pathogenic ★★★ same condition
MAP2K1 p.Leu42Arg Likely pathogenic ★★★ same condition
MAP2K1 p.Leu42Phe Pathogenic ★★★ same condition
MAP2K1 p.Leu92Arg Pathogenic ★★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/map2k1-p-lys4arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown